在哥本哈根和华盛顿之间的紧张局势发酵之际，丹麦制药商诺和诺德公司首席执行官表示，该公司为特朗普发动潜在关税战做好了准备。

　　特朗普对主要贸易伙伴加拿大、墨西哥和中国的关税威胁导致一些制造业企业纷纷采取应对措施。对于治疗糖尿病的Ozempic和减肥疗法Wegovy等诺和诺德明星产品而言，美国是一大关键市场。

　　诺和诺德首席执行官Lars Fruergaard Jorgensen周三接受彭博电视采访时表示，该公司在美国拥有超过10000名员工，在美供应链的大部分“将在很大程度上”满足当地的需求，“基准情境是我们可以应对这种情况。”

　　在美国与丹麦就格陵兰问题发生冲突之际，特朗普发出关税威胁。诺和诺德股价在哥本哈根日间一度上涨6.3%，因该公司预测2025年销售激增的幅度超过分析师的预期。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：李桐

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.